NEUTRISCI INTERNATIONAL INC (NU.CA) Fundamental Analysis & Valuation

TSX-V:NU • CA64129Y1079

Current stock price

0.005 CAD
0 (0%)
Last:

This NU.CA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. NU.CA Profitability Analysis

1.1 Basic Checks

  • In the past year NU has reported negative net income.
  • NU had a negative operating cash flow in the past year.
NU.CA Yearly Net Income VS EBIT VS OCF VS FCFNU.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 -500K -1M -1.5M -2M -2.5M

1.2 Ratios

  • The Return On Assets of NU (-432.18%) is worse than 60.00% of its industry peers.
Industry RankSector Rank
ROA -432.18%
ROE N/A
ROIC N/A
ROA(3y)-264.66%
ROA(5y)-308.79%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
NU.CA Yearly ROA, ROE, ROICNU.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 0 2K -2K -4K -6K -8K

1.3 Margins

  • NU does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
NU.CA Yearly Profit, Operating, Gross MarginsNU.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 0 -500 -1K -1.5K -2K -2.5K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

0

2. NU.CA Health Analysis

2.1 Basic Checks

  • NU does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, NU has more shares outstanding
  • Compared to 1 year ago, NU has a worse debt to assets ratio.
NU.CA Yearly Shares OutstandingNU.CA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 50M 100M 150M
NU.CA Yearly Total Debt VS Total AssetsNU.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 200K 400K 600K 800K 1M

2.2 Solvency

  • Based on the Altman-Z score of -422.87, we must say that NU is in the distress zone and has some risk of bankruptcy.
  • With a Altman-Z score value of -422.87, NU is not doing good in the industry: 60.00% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -422.87
ROIC/WACCN/A
WACC7.56%
NU.CA Yearly LT Debt VS Equity VS FCFNU.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 0 500K -500K -1M -1.5M -2M

2.3 Liquidity

  • A Current Ratio of 0.02 indicates that NU may have some problems paying its short term obligations.
  • Looking at the Current ratio, with a value of 0.02, NU is doing worse than 80.00% of the companies in the same industry.
  • NU has a Quick Ratio of 0.02. This is a bad value and indicates that NU is not financially healthy enough and could expect problems in meeting its short term obligations.
  • With a Quick ratio value of 0.01, NU is not doing good in the industry: 80.00% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.02
Quick Ratio 0.01
NU.CA Yearly Current Assets VS Current LiabilitesNU.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 200K 400K 600K 800K 1M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. NU.CA Growth Analysis

3.1 Past

  • NU shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 42.21%, which is quite impressive.
  • Looking at the last year, NU shows a very negative growth in Revenue. The Revenue has decreased by -86.13% in the last year.
  • Measured over the past years, NU shows a very strong growth in Revenue. The Revenue has been growing by 24.82% on average per year.
EPS 1Y (TTM)42.21%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%12.7%
Revenue 1Y (TTM)-86.13%
Revenue growth 3Y68%
Revenue growth 5Y24.82%
Sales Q2Q%-46.99%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
NU.CA Yearly Revenue VS EstimatesNU.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 100K 200K 300K 400K

More info and screens

Find the best growth stocksShow best growing peers

0

4. NU.CA Valuation Analysis

4.1 Price/Earnings Ratio

Industry RankSector Rank
PE N/A
Fwd PE N/A
NU.CA Price Earnings VS Forward Price EarningsNU.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
NU.CA Per share dataNU.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0 -0 -0 -0 -0

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. NU.CA Dividend Analysis

5.1 Amount

  • NU does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Find the best dividend stocksShow peers with best dividend

NU.CA Fundamentals: All Metrics, Ratios and Statistics

NEUTRISCI INTERNATIONAL INC

TSX-V:NU (5/7/2024, 7:00:00 PM)

0.005

0 (0%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Earnings (Last)N/A
Earnings (Next)N/A
Inst Owners1.29%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap892.12K
Revenue(TTM)59.98K
Net Income(TTM)-552.46K
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 14.87
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)0
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0
FCFYN/A
OCF(TTM)0
OCFYN/A
SpS0
BVpS-0.01
TBVpS-0.01
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -432.18%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-264.66%
ROA(5y)-308.79%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score1
Asset Turnover0.47
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 0%
Cap/Sales 0%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.02
Quick Ratio 0.01
Altman-Z -422.87
F-Score1
WACC7.56%
ROIC/WACCN/A
Cap/Depr(3y)218.54%
Cap/Depr(5y)279.44%
Cap/Sales(3y)94%
Cap/Sales(5y)63.22%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)42.21%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%12.7%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-86.13%
Revenue growth 3Y68%
Revenue growth 5Y24.82%
Sales Q2Q%-46.99%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y37.35%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y77.41%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y74.07%
OCF growth 3YN/A
OCF growth 5YN/A

NEUTRISCI INTERNATIONAL INC / NU.CA Fundamental Analysis FAQ

What is the fundamental rating for NU stock?

ChartMill assigns a fundamental rating of 1 / 10 to NU.CA.


What is the valuation status of NEUTRISCI INTERNATIONAL INC (NU.CA) stock?

ChartMill assigns a valuation rating of 0 / 10 to NEUTRISCI INTERNATIONAL INC (NU.CA). This can be considered as Overvalued.


What is the profitability of NU stock?

NEUTRISCI INTERNATIONAL INC (NU.CA) has a profitability rating of 0 / 10.


What is the financial health of NEUTRISCI INTERNATIONAL INC (NU.CA) stock?

The financial health rating of NEUTRISCI INTERNATIONAL INC (NU.CA) is 0 / 10.